AMYLYX PHARMACEUTICALS, INC.

Insiders Amylyx Pharmaceuticals, Inc.

Equities

AMLX

US03237H1014

Market Closed - Nasdaq Other stock markets 04:00:00 2024-05-14 pm EDT			5-day change	1st Jan Change
1.87 ^USD	+2.75%		-5.08%	-87.30%

01:29pm	Mizuho Cuts Price Target on Amylyx Pharmaceuticals to $3 From $4, Keeps Neutral Rating	MT
May. 09	Transcript : Amylyx Pharmaceuticals, Inc., Q1 2024 Earnings Call, May 09, 2024

Insiders

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Amylyx Pharmaceuticals, Inc. Appoints Bernhardt Zeiher to Its Board of Directors	Mar. 14	CI
Amylyx Pharmaceuticals Appoints Camille L. Bedrosian as Chief Medical Officer	Nov. 28	CI
Insider Sell: Amylyx Pharmaceuticals	23-08-17	MT
Insider Sell: Amylyx Pharmaceuticals	23-05-17	MT
Amylyx Pharmaceuticals, Inc. Announces Appointment of Masako Nakamura as Head of International Markets - Asia Pacific and Latin America	23-04-20	CI
Insider Sell: Amylyx Pharmaceuticals	23-04-20	MT
Amylyx Pharmaceuticals, Inc. Appoints Karen Firestone as Class I Director	23-03-21	CI
Insider Sell: Amylyx Pharmaceuticals	23-03-21	MT
Insider Sell: Amylyx Pharmaceuticals	23-03-21	MT
Insider Sell: Amylyx Pharmaceuticals	23-03-21	MT
Insider Sell: Amylyx Pharmaceuticals	23-03-21	MT
Amylyx Pharmaceuticals, Inc. Announces Resignation of Isaac Cheng as Board of Directors	22-11-02	CI
Amylyx Pharmaceuticals Inc. Expands Executive Team with Appointment of Gina M. Mazzariello as Chief Legal Officer and General Counsel	22-02-23	CI
Amylyx Pharmaceuticals Appoints Walter Gilbert to Board of Directors	16-01-19	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.

SIGN UP NOW